The New York Times reports on the efforts of Dr. Peter C. Butler, an internationally recognized diabetes expert described as a “crusader” for his attempts to warn about an apparent link between certain medications and potentially deadly pancreas ailments.
The report says Butler’s involvement in the issue began when he did a study on behalf of pharmaceutical manufacturer Merck, to test the effectiveness of its drug Januvia in treating diabetes.
When Butler ...
continue reading...